BB2603
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BB2603, covering 2023-08-01 to 2023-08-01. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail [Phase 2]